Corgi Genomics & Prec MedGNMXETF

13F holders, Q2 2026 (June 30)
1holders
$31.09avg. 13F price*

At the end of Q2 2026, 1 institutions reported holding Corgi Genomics & Prec Med (GNMX) in their 13F filings. The largest holder was GTS Securities LLC ($387K).

Company
Corgi Genomics & Prec Med
Filed as
CORGI ETF TR I (Q2 2026)
CUSIP
218946846
Latest filing quarter
Q2 2026

Total Exit/New Position Q2 2026

InstitutionsTotal Value
New Positions1$387K
Exits0$0

Ownership 1 holders

GTS Securities LLC 0.01% New 12,435 $387K

"% of holder's portfolio" is GNMX's weight in each manager's 13F, not the share of Corgi Genomics & Prec Med the manager owns.